90 related articles for article (PubMed ID: 2174216)
1. Neuropeptide Y and its receptor antagonists. Use of an analog mixture-screening strategy.
Tatemoto K
Ann N Y Acad Sci; 1990; 611():1-6. PubMed ID: 2174216
[No Abstract] [Full Text] [Related]
2. Synthesis of receptor antagonists of neuropeptide Y.
Tatemoto K; Mann MJ; Shimizu M
Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1174-8. PubMed ID: 1311083
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.
Dumont Y; Martel JC; Fournier A; St-Pierre S; Quirion R
Prog Neurobiol; 1992; 38(2):125-67. PubMed ID: 1312243
[No Abstract] [Full Text] [Related]
4. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization.
Dumont Y; Quirion R
EXS; 2006; (95):7-33. PubMed ID: 16382995
[No Abstract] [Full Text] [Related]
5. Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms.
McDermott BJ; Millar BC; Piper HM
Cardiovasc Res; 1993 Jun; 27(6):893-905. PubMed ID: 8221778
[No Abstract] [Full Text] [Related]
6. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
Krause J; Eva C; Seeburg PH; Sprengel R
Mol Pharmacol; 1992 May; 41(5):817-21. PubMed ID: 1316999
[TBL] [Abstract][Full Text] [Related]
7. High-affinity analogues of neuropeptide Y containing conformationally restricted non-proteinogenic amino acids.
Beck-Sickinger AG; Hoffmann E; Paulini K; Reissig HU; Willim KD; Wieland HA; Jung G
Biochem Soc Trans; 1994 Feb; 22(1):145-9. PubMed ID: 8206212
[No Abstract] [Full Text] [Related]
8. Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?
Wahlestedt C; Reis DJ
Annu Rev Pharmacol Toxicol; 1993; 33():309-52. PubMed ID: 8494343
[No Abstract] [Full Text] [Related]
9. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
Singh G; Singh L; Raufman JP
Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
[TBL] [Abstract][Full Text] [Related]
10. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
[TBL] [Abstract][Full Text] [Related]
11. First selective agonist of the neuropeptide Y1-receptor with reduced size.
Zwanziger D; Böhme I; Lindner D; Beck-Sickinger AG
J Pept Sci; 2009 Dec; 15(12):856-66. PubMed ID: 19890892
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the ligand-receptor interaction of neuropeptide Y.
Ingenhoven N; Beck-Sickinger AG
Curr Med Chem; 1999 Nov; 6(11):1055-66. PubMed ID: 10519913
[TBL] [Abstract][Full Text] [Related]
13. [Peptide YY and neuropeptide Y in the intestine: availability, biologic effects and epithelial receptors].
Laburthe M
Arch Int Physiol Biochim Biophys; 1991 Sep; 99(5):A177. PubMed ID: 1720689
[No Abstract] [Full Text] [Related]
14. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
[TBL] [Abstract][Full Text] [Related]
15. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.
McAuley MA; Westfall TC
J Pharmacol Exp Ther; 1992 Jun; 261(3):863-8. PubMed ID: 1351098
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y receptor subtypes, Y1 and Y2.
Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
[TBL] [Abstract][Full Text] [Related]
17. A receptor subtype involved in neuropeptide-Y-induced food intake.
Gerald C; Walker MW; Criscione L; Gustafson EL; Batzl-Hartmann C; Smith KE; Vaysse P; Durkin MM; Laz TM; Linemeyer DL; Schaffhauser AO; Whitebread S; Hofbauer KG; Taber RI; Branchek TA; Weinshank RL
Nature; 1996 Jul; 382(6587):168-71. PubMed ID: 8700207
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the Y-1 receptor subtype in the regulation of luteinizing hormone secretion by neuropeptide Y in rats.
Kalra SP; Fuentes M; Fournier A; Parker SL; Crowley WR
Endocrinology; 1992 Jun; 130(6):3323-30. PubMed ID: 1317781
[TBL] [Abstract][Full Text] [Related]
19. High-affinity neuropeptide Y receptor antagonists.
Daniels AJ; Matthews JE; Slepetis RJ; Jansen M; Viveros OH; Tadepalli A; Harrington W; Heyer D; Landavazo A; Leban JJ; Spaltenstein A
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9067-71. PubMed ID: 7568074
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
Beck-Sickinger AG; Jung G
Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
